Oct 01, 2021 · Encounter for antenatal screening for nuchal translucency. 2018 - New Code 2019 2020 2021 2022 Billable/Specific Code Maternity Dx (12-55 years) POA Exempt. Z36.82 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z36.82 became effective on October 1, 2021.
2022 ICD-10-CM Code Z36.82 Encounter for antenatal screening for nuchal translucency. ICD-10-CM Index; Chapter: Z00–Z99; Section: Z30-Z39; Block: Z36; Z36.82 - Encounter for antenatal screening for nuchal translucency
ICD-10 code Z36.82 for Encounter for antenatal screening for nuchal translucency is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z36.82 Encounter for antenatal screening for nuchal translucency Z36.83 Encounter for fetal screening for congenital cardiac abnormalities Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Z36.82 is a billable diagnosis code used to specify a medical diagnosis of encounter for antenatal screening for nuchal translucency. The code Z36.82 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.#N#The code Z36.82 is applicable to female patients aged 12 through 55 years inclusive. It is clinically and virtually impossible to use this code on a non-female patient outside the stated age range.
Z36.82 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnos is codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
Screening is the testing for disease or disease precursors in asympto matic individuals so that early detection and treatment can be provided for those who test positive for the disease. Excludes1: diagnostic examination- code to sign or symptom. encounter for suspected maternal and fetal conditions ruled out ( Z03.7 -)
Includes: Encounter for placental sample (taken vaginally)#N#Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
The 2021 edition of ICD-10-CM Z36 became effective on October 1, 2020.
Z36 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. The 2021 edition of ICD-10-CM Z36 became effective on October 1, 2020. This is the American ICD-10-CM version of Z36 - other international versions of ICD-10 Z36 may differ. Type 1 Excludes.
Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed.